Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatoid Arthritis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatoid Arthritis
    TopAbstracts in Rheumatoid Arthritis 11/26/2009 - (DGNews)
    TopAbstracts in Rheumatoid Arthritis 11/12/2009 - (DGNews)
    Anti-TNF Treatment Does Not Increase Cancer Risk in Patients With RA - (DGNews)
    TopAbstracts in Rheumatoid Arthritis 10/29/2009 - (DGNews)
    Tocilizumab Plus Methotrexate Provides Sustained Benefits in Patients With RA: Presented at ACR/ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatoid Arthritis
      Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?
      Advances in Basic Science
      Quantitatively-Driven Management of Rheumatoid Arthritis
      Cancer, Liver, Infections, Cardiovascular Disease, and other Biologic Agents
      Rheumatoid Arthritis: Clinical Aspects, Outcomes, and Measures

      Webcasts/CME archive

       Recent cases - Rheumatoid Arthritis
        Mesenteric Rheumatoid Nodules Masquerading as an Intra-Abdominal Malignancy: A Case Report and Review of the Literature
        Co-Existence of Acute Myeloid Leukemia with Multilineage Dysplasia and Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis
        Patient with Hepatitis B and Rheumatoid Arthritis
        Complete Heart Block and Severe Aortic Stenosis in a Patient with Rheumatoid Arthtritis: A Case Report
        Limited Wegener's Granulomatosis Presenting as Lung Nodules in a Patient with Rheumatoid Arthritis: A Case Report

        Cases archive
          




        my personal edition > rheumatoid arthritis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Weekly Methotrexate As Effective as Twice-Weekly For Rheumatoid Arthritis

        A DGReview of :"Methotrexate twice weekly vs once weekly in rheumatoid arthritis: a pilot double-blind, controlled study"
        Rheumatology International

        05/29/2002
        By Anne MacLennan


        Twice-weekly methotrexate for patients with rheumatoid arthritis is no more efficient than is the currently used once-weekly regimen, suggests a study from India.

        Researchers from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, undertook this 16-week double blind, controlled trial of twice-weekly versus weekly regimens of methotrexate (MTX).

        Eighty people fulfilling the American College of Rheumatology (ACR) criteria for rheumatoid arthritis (RA) participated in this study. The researchers determined patients achieving ACR scores of 20 and 50 at both eight and 16 weeks and also examined the incidence of hepatotoxicity.

        Of the 80 patients, 66 completed eight weeks of study and 53 completed 16 weeks. Most of those who withdrew from the study did so because of inefficacy.

        At eight weeks, the ACR 20 response (24/34 in once weekly and 22/32 in twice weekly) and ACR 50 response (16/34 in once weekly and 16/32 in twice weekly) in both groups were similar.

        Even at 16 weeks, there was no significant difference in ACR 20 and ACR 50 responses. There were similar results in an intent-to-treat analysis.

        Five patients in each group had a mild reversible rise in transaminases.
        Rheumatol Int (2002) 22: 1-4. "Methotrexate twice weekly vs once weekly in rheumatoid arthritis: a pilot double-blind, controlled study"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send